A detailed history of Aqr Capital Management LLC transactions in Liva Nova PLC stock. As of the latest transaction made, Aqr Capital Management LLC holds 413,867 shares of LIVN stock, worth $21.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
413,867
Previous 129,871 218.68%
Holding current value
$21.2 Million
Previous $7.12 Million 205.27%
% of portfolio
0.03%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.38 - $54.59 $12.3 Million - $15.5 Million
283,996 Added 218.68%
413,867 $21.7 Million
Q2 2024

Aug 14, 2024

BUY
$51.76 - $64.15 $48,136 - $59,659
930 Added 0.72%
129,871 $7.12 Million
Q1 2024

May 15, 2024

BUY
$48.6 - $57.12 $2.83 Million - $3.32 Million
58,193 Added 82.25%
128,941 $7.21 Million
Q4 2023

Feb 14, 2024

SELL
$43.45 - $53.66 $2.07 Million - $2.55 Million
-47,610 Reduced 40.23%
70,748 $3.66 Million
Q3 2023

Nov 14, 2023

SELL
$50.12 - $58.87 $2.01 Million - $2.37 Million
-40,176 Reduced 25.34%
118,358 $6.26 Million
Q2 2023

Aug 14, 2023

BUY
$42.28 - $51.43 $2.75 Million - $3.34 Million
64,955 Added 69.41%
158,534 $8.15 Million
Q1 2023

May 15, 2023

BUY
$40.84 - $58.14 $1.79 Million - $2.56 Million
43,946 Added 88.54%
93,579 $4.08 Million
Q4 2022

Feb 14, 2023

BUY
$43.88 - $56.16 $1.17 Million - $1.49 Million
26,613 Added 115.61%
49,633 $2.76 Million
Q3 2022

Nov 14, 2022

SELL
$48.37 - $66.5 $1.1 Million - $1.52 Million
-22,809 Reduced 49.77%
23,020 $1.17 Million
Q2 2022

Aug 15, 2022

SELL
$57.25 - $86.63 $405,330 - $613,340
-7,080 Reduced 13.38%
45,829 $2.83 Million
Q1 2022

May 16, 2022

BUY
$71.02 - $86.99 $2.16 Million - $2.65 Million
30,478 Added 135.87%
52,909 $4.33 Million
Q4 2021

Feb 14, 2022

BUY
$76.72 - $92.68 $405,925 - $490,369
5,291 Added 30.87%
22,431 $1.96 Million
Q3 2021

Nov 15, 2021

BUY
$76.02 - $88.62 $288,191 - $335,958
3,791 Added 28.4%
17,140 $1.36 Million
Q2 2021

Aug 16, 2021

BUY
$73.44 - $87.01 $279,218 - $330,812
3,802 Added 39.82%
13,349 $1.12 Million
Q1 2021

May 17, 2021

SELL
$62.9 - $82.41 $800,088 - $1.05 Million
-12,720 Reduced 57.12%
9,547 $704,000
Q4 2020

Feb 16, 2021

BUY
$46.01 - $68.74 $558,055 - $833,747
12,129 Added 119.64%
22,267 $1.47 Million
Q3 2020

Nov 16, 2020

SELL
$41.91 - $57.81 $194,127 - $267,775
-4,632 Reduced 31.36%
10,138 $446,000
Q2 2020

Aug 17, 2020

SELL
$39.87 - $56.9 $2.62 Million - $3.74 Million
-65,670 Reduced 81.64%
14,770 $692,000
Q1 2020

May 15, 2020

SELL
$34.22 - $76.49 $102,591 - $229,317
-2,998 Reduced 3.59%
80,440 $3.64 Million
Q4 2019

Feb 14, 2020

BUY
$68.92 - $85.27 $2.06 Million - $2.55 Million
29,851 Added 55.71%
83,438 $6.29 Million
Q3 2019

Nov 14, 2019

SELL
$71.74 - $86.35 $13.8 Million - $16.6 Million
-192,530 Reduced 78.23%
53,587 $3.95 Million
Q2 2019

Aug 14, 2019

BUY
$66.45 - $97.36 $6.69 Million - $9.8 Million
100,705 Added 69.25%
246,117 $17.7 Million
Q1 2019

May 14, 2019

SELL
$86.15 - $100.49 $6.33 Million - $7.39 Million
-73,522 Reduced 33.58%
145,412 $14.1 Million
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $308,373 - $459,664
-3,665 Reduced 1.65%
218,934 $20 Million
Q3 2018

Nov 15, 2018

BUY
$101.02 - $130.95 $11.6 Million - $15 Million
114,886 Added 106.66%
222,599 $27.6 Million
Q2 2018

Aug 14, 2018

BUY
$81.75 - $105.37 $6.09 Million - $7.85 Million
74,519 Added 224.5%
107,713 $10.8 Million
Q1 2018

May 15, 2018

BUY
$79.95 - $89.74 $1.86 Million - $2.08 Million
23,226 Added 233.01%
33,194 $2.94 Million
Q4 2017

Feb 14, 2018

BUY
$71.8 - $88.21 $418,953 - $514,705
5,835 Added 141.18%
9,968 $797,000
Q3 2017

Nov 14, 2017

BUY
$60.32 - $70.06 $249,302 - $289,557
4,133
4,133 $290,000

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.75B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.